3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Renal Cell
24
Kidney Neoplasms
10
Neoplasms
9
Carcinoma
6
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Carcinoma, Non-Small-Cell Lung
4
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Lung Neoplasms
2
Kidney Diseases
2
Glioblastoma
2
Carcinoma, Adenoid Cystic
2
Breast Neoplasms
2
Advanced Solid Tumors
2
cT2a N0NxM0 Renal Tumor
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Solitary Fibrous Tumors
1
Solid Tumors
1
Solid Malignancies
1
Skin Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Salivary Gland Neoplasms
1
Refractory or Recurrent Solid Tumors, Excluding CNS Tumors
1
Prostatic Neoplasms
1
Interventions
Cisplatin
72
Brachytherapy
31
Radiotherapy
26
Paclitaxel
23
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
21
human papillomavirus vaccine, L1 type 16, 18
20
Topotecan
18
Papillomavirus Vaccines
18
Carboplatin
18
Surveys and Questionnaires
17
Bevacizumab
16
pembrolizumab
14
Radiation
12
Gemcitabine
12
Early Intervention, Educational
12
Colposcopy
12
Methods
11
Magnetic Resonance Spectroscopy
11
atezolizumab
10
Radiotherapy, Intensity-Modulated
10
Blood Specimen Collection
10
Papanicolaou Test
9
Docetaxel
9
Vaccines, Synthetic
8
Platinum
8
Nivolumab
8
Ipilimumab
8
Counseling
8
1,2-diaminocyclohexaneplatinum II citrate
8
Vaccines
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Uterine Cervical Neoplasms
×
Axitinib
×
Clear all
NCT03826589
2025-06-11
ALARICE
The University of Hong Kong
Phase NA
Completed
23 enrolled